Who Benefits from SLIT?

Allergy is about more than the common symptoms we associate with it. Allergy can be the underlying cause or a related issue with chronic health problems – often not looking like typical allergic issues.

Most people with chronic allergies and related illnesses can benefit from sublingual immunotherapy (SLIT). Treatment can be especially helpful for those who can’t tolerate, don’t respond to, or aren’t able to comply with allergy injections. SLIT using the La Crosse Method™ Protocol is designed for patient safety and comfort, enabling a wider range of patients to receive the long-term benefit of immunotherapy.

Key populations for consideration:

  • Infants & children. Allergy drops have proven especially helpful for children with eczema and recurrent ear infections, which often have underlying allergic causes; early treatment can halt the atopic march.
  • Patients with asthma. Sublingual immunotherapy can provide desensitization for allergic triggers; reduce symptoms and the need for asthma medications.
  • Patients with chronic conditions including sinusitis. Research shows that a majority of chronic sinus conditions are triggered by mold allergies. Sublingual immunotherapy treats the underlying mold allergy, reducing incidence of sinusitis and improving related surgical outcomes.
  • Patients with food and mold allergies. Sublingual immunotherapy provides an alternative to avoidance. Clinical evidence demonstrates that even the most sensitive patients can tolerate SLIT, and research shows positive clinical outcomes that reduce risk in case of accidental ingestion.
  • Highly sensitive patients. For patients who have experienced systemic reactions to injection immunotherapy, who are needle phobic, or cannot commit to injections, SLIT provides a safe, patient-friendly approach to treating the underlying cause of allergic disease.
  • Patients with multiple allergies. Sublingual immunotherapy patients with multiple allergies including dust, pollens, dander, molds and even foods have shown marked clinical improvements following treatment that addresses allergies simultaneously.

Treating the underlying allergy can improve symptoms and reduces the likelihood of new allergies developing. In the long-run, SLIT has benefits patients can’t achieve from temporary symptom-relieving medications.